CEO Nils Brünner and CEO Per Norlén (Alligator Bioscience) comments on the preclinical collaboration

CEO Nils Brünner (Scandion Oncology) and CEO Per Norlén (Alligator Bioscience) comments on the preclinical collaboration in the BioStock Studio.
>https://www.biostock.se/2020/06/biostock-studio-scandion-oncology-och-alligator-bioscience-kommenterar-prekliniskt-samarbete/

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union